Sinha Vikas (CIK 0001337845)

Latest company ownership

Shares held
16,674,766
Last filed at
Aug 20, 2024
Confidence Score
50.1
2025Q4
Confidence Score History
2022Q1 2025Q4
VRNA - Verona Pharma plc
Role: Director
Shares held
64,000
Last filed at
Oct 8, 2025
Confidence Score
46.2
2025Q4
Confidence Score History
2021Q1 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Aug 1, 2025 Aug 5, 2025 Verona Pharma plc Director Sell 42.5 -4,328 -4.40% ✗ $56.9K
May 20, 2025 May 22, 2025 Verona Pharma plc Director Sell 5.0 -160,000 -68.25% ✓ $1.5M
Apr 29, 2025 May 22, 2025 Verona Pharma plc Director Sell 5.0 -160,000 -51.80% ✓ $1.4M
Apr 29, 2025 May 1, 2025 Verona Pharma plc Director Sell 25.0 -20,000 -11.84% ✓ $178.4K
Feb 21, 2025 Feb 24, 2025 Kalaris Therapeutics, Inc. Officer Sell 52.5 -303 -0.04% ✗ $3.1K
Jan 23, 2025 Jan 27, 2025 Kalaris Therapeutics, Inc. Officer Sell 52.5 -129 -0.02% ✗ $1.2K
Jan 10, 2025 Jan 13, 2025 Kalaris Therapeutics, Inc. Officer Sell 52.5 -979 -0.01% ✗ $430.9
Nov 19, 2024 Nov 20, 2024 Kalaris Therapeutics, Inc. Officer Sell 52.5 -3,186 -0.02% ✗ $1.7K
Nov 5, 2024 Nov 6, 2024 Kalaris Therapeutics, Inc. Officer Sell 52.5 -5,136 -0.03% ✗ $4.4K
Oct 21, 2024 Oct 23, 2024 Kalaris Therapeutics, Inc. Officer Sell 52.5 -3,428 -0.02% ✗ $2.6K
Oct 3, 2024 Oct 4, 2024 Kalaris Therapeutics, Inc. Officer Sell 52.5 -940 -0.01% ✗ $765.9
Aug 19, 2024 Aug 20, 2024 Kalaris Therapeutics, Inc. Officer Sell 52.5 -3,159 -0.02% ✗ $2.4K
Aug 5, 2024 Aug 7, 2024 Kalaris Therapeutics, Inc. Officer Sell 52.5 -5,251 -0.03% ✗ $3.9K
Jul 19, 2024 Jul 23, 2024 Kalaris Therapeutics, Inc. Officer Sell 52.5 -3,400 -0.02% ✗ $2.5K
Jul 2, 2024 Jul 3, 2024 Kalaris Therapeutics, Inc. Officer Sell 52.5 -939 -0.01% ✗ $676.1
May 17, 2024 May 21, 2024 Kalaris Therapeutics, Inc. Officer Sell 52.5 -3,143 -0.02% ✗ $2.4K
May 3, 2024 May 7, 2024 Kalaris Therapeutics, Inc. Officer Sell 52.5 -4,957 -0.03% ✗ $3.9K
Apr 19, 2024 Apr 23, 2024 Kalaris Therapeutics, Inc. Officer Sell 52.5 -3,378 -0.02% ✗ $2.5K
Apr 2, 2024 Apr 4, 2024 Kalaris Therapeutics, Inc. Officer Sell 52.5 -885 0.00% ✗ $683.2
Feb 20, 2024 Feb 22, 2024 Kalaris Therapeutics, Inc. Officer Sell 52.5 -2,893 -0.02% ✗ $2K
Feb 5, 2024 Feb 6, 2024 Kalaris Therapeutics, Inc. Officer Sell 51.3 -18,331 -0.10% ✗ $12.3K
Jan 23, 2024 Jan 25, 2024 Kalaris Therapeutics, Inc. Officer Sell 52.5 -3,205 -0.02% ✗ $2.1K
Jan 4, 2024 Jan 8, 2024 Kalaris Therapeutics, Inc. Officer Sell 52.5 -961 -0.01% ✗ $614.1
Nov 17, 2023 Nov 21, 2023 Kalaris Therapeutics, Inc. Officer Sell 52.5 -2,490 -0.01% ✗ $4.1K
Oct 19, 2023 Oct 23, 2023 Kalaris Therapeutics, Inc. Officer Sell 52.5 -2,707 -0.02% ✗ $4.2K
Oct 3, 2023 Oct 5, 2023 Kalaris Therapeutics, Inc. Officer Sell 52.5 -755 0.00% ✗ $1.5K
Aug 17, 2023 Aug 21, 2023 Kalaris Therapeutics, Inc. Officer Sell 51.3 -10,516 -0.06% ✗ $26.2K
Jul 19, 2023 Jul 21, 2023 Kalaris Therapeutics, Inc. Officer Sell 52.5 -2,635 -0.01% ✗ $9.1K
Jul 5, 2023 Jul 6, 2023 Kalaris Therapeutics, Inc. Officer Sell 52.5 -2,983 -0.02% ✗ $9.1K
Apr 19, 2023 Apr 21, 2023 Kalaris Therapeutics, Inc. Officer Sell 52.5 -2,683 -0.02% ✗ $9.8K
Jan 19, 2023 Jan 23, 2023 Kalaris Therapeutics, Inc. Officer Sell 57.5 -6,537 -0.04% ✓ $33.3K
Oct 20, 2022 Oct 26, 2022 Kalaris Therapeutics, Inc. Officer Sell 51.3 -1,449 -0.14% ✗ $13.6K
Oct 19, 2022 Oct 24, 2022 Kalaris Therapeutics, Inc. Officer Sell 51.3 -1,449 -0.01% ✗ $13.6K
Jul 20, 2022 Jul 21, 2022 Kalaris Therapeutics, Inc. Officer Sell 52.5 -1,432 -0.01% ✗ $7.5K
Apr 20, 2022 Apr 22, 2022 Kalaris Therapeutics, Inc. Officer Sell 52.5 -1,162 -0.01% ✗ $7.8K
Jan 20, 2022 Jan 24, 2022 Kalaris Therapeutics, Inc. Officer Sell 47.5 -6,450 -0.05% ✗ $56.5K
May 4, 2021 May 5, 2021 Verona Pharma plc Director Sell 30.0 -10,016 -11.86% ✓ $8.4K
Feb 1, 2021 Feb 3, 2021 Verona Pharma plc Director Sell 28.8 -10,224 -10.80% ✓ $10.2K